ISSAQUAH, Wash., March 05, 2026 (GLOBE NEWSWIRE) — Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced its operating results for the second quarter (twelve weeks) and the first 24 weeks of fiscal 2026, ended February 15, 2026. Net sales for the quarter increased 9.1 percent, to $68.24 billion, from $62.53 billion last year. Net sales for the first 24 weeks increased 8.7 percent, to $134.22 billion, from $123.52 billion last year. Comparable sales for the second quarter and first 24 weeks of fiscal 2026 were as follows:    12 Weeks   12 Weeks   24 Weeks   24 Weeks          Adjusted*       Adjusted*    U.S. 5.9%   6.4%   5.9%   6.1%    Canada 10.1%   7.6%   8.3%   8.3%    Other International 13.0%   7.1%   11.0%   7.0%                       Total Company 7.4%   6.7%   6.9%   6.5%                       Digitally-Enabled 22.6%   21.7%   21.6%   21.2%  *Excluding...

SAN RAMON, Calif., March 05, 2026 (GLOBE NEWSWIRE) — CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2026.First quarter 2026 revenue of $1.024 billion, up 6%, or up 3% organically, from last year’s first quarter. First quarter 2026 GAAP diluted earnings per share (EPS) of $0.66, up $0.14 or 27% from last year’s first quarter. First quarter 2026 Non-GAAP diluted EPS of $1.10, up $0.18 or 20% from last year’s first quarter. See “Reconciliation of Selected GAAP Results to Non-GAAP Results” below.“We’re pleased to report a strong start to the fiscal year, highlighted by product launches, outstanding profitability, and robust cash flow, all of which gives us the confidence to raise both...

Fourth Quarter Sales of $65.4 million, Adjusted EBITDA of $1.2 million, and Free Cash Flow of $11.6 million Continued Focus on Simplification Strategy to Position Company for Profitable Growth Apparel Sales in the Outdoor segment up 10% in the Fourth Quarter SALT LAKE CITY, March 05, 2026 (GLOBE NEWSWIRE) — Clarus Corporation (NASDAQ: CLAR) (“Clarus” and/or the “Company”), a global company focused on the outdoor enthusiast markets, reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Summary vs. Same Year‐Ago QuarterSales of $65.4 million compared to $71.4 million. Gross margin was 27.7% compared to 33.4%; adjusted gross margin of 33.6% compared to 38.0%. Net loss of $31.3 million, or $(0.81) per diluted share1, compared to net loss(including the impact of discontinued...

Net Sales Growth of ~2% Year-Over-YearHealthy Balance Sheet and Strong LiquidityWell Positioned to Capitalize on Pent-Up Demand HOUSTON, March 05, 2026 (GLOBE NEWSWIRE) — Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended January 31, 2026.   The Company reported the following selected financial results:  Three Months Ended January 31,($ in millions, except per share data) 2026   2025Net Sales $409.1   $400.0Gross Margin $98.5   $92.3Gross Margin % 24.1%   23.1%Net Loss ($4.1)   ($14.9)Diluted EPS ($0.09)   ($0.32)       Adjusted Net (Loss) Income ($0.3)   $9.0Adjusted Diluted EPS ($0.01)   $0.19Adjusted EBITDA $27.4   $38.5Adjusted EBITDA Margin % 6.7%   9.6%       Cash Used For Operating Activities ($20.2)   ($12.5)Free...

Strongest Quarterly and Annual Results in Company History Q4 GAAP Net Combined Ratio of 64.2% | Q4 Diluted EPS of $1.03 | Q4 Annualized ROE of 51.3%Q4 Diluted Operating EPS1 of $1.08 | FY Net Income of $40.8M, up 122% | FY Book Value per Share of $8.28 up 75%Net Premiums Earned Growth of 46% for FY 2025 |Direct Premiums Written Growth1 of 15% for FY 2025  Updates 2026 Guidance Management to Host Conference Call Tomorrow at 8:30 a.m. Eastern Time KINGSTON, N.Y., March 05, 2026 (GLOBE NEWSWIRE) — Kingstone Companies, Inc. (Nasdaq:  KINS) (“Kingstone” or the “Company”), a Northeast regional property and casualty insurance holding company, today announced its financial results for the fourth quarter and year ended December 31, 2025.  The Company has also provided an investor presentation that can be accessed through the News &...

OAKLAND, Calif., March 05, 2026 (GLOBE NEWSWIRE) — ContextLogic Holdings Inc. (OTCQB: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the fourth quarter and fiscal year ended December 31, 2025. Company Update Subsequent to the end of the fourth quarter 2025, the Company completed the acquisition of US Salt Parent Holdings, LLC and its subsidiaries (together, “US Salt”), marking a pivotal milestone in ContextLogic’s evolution into a business ownership platform. The Company remains focused on identifying and pursuing additional acquisitions of businesses that are niche, competitively advantaged, and built for long-duration value creation. Fourth-Quarter Fiscal 2025 Financial HighlightsOn December 8, 2025, ContextLogic announced the planned $907.5 million acquisition...

2025, a Transformational Year Marked by Strategic Steps Designed to Enhance Shareholder Value: the Merger with Logan Ridge, Corporate Rebranding and Completion of a Tender Offer  Announces First Quarter 2026 Quarterly Distribution of $0.32 Per Share; Transition to New Monthly Base Distributions of $0.09 Per Share Beginning April 2026 with the Potential for Quarterly Supplemental Distributions; Total Distributions for 2025 of $1.97 Per Share NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) — BCP Investment Corporation (NASDAQ: BCIC) (“BCIC” or “the Company”) announced today its financial results for the fourth quarter and full year ended December 31, 2025. Full Year 2025 MilestonesOn July 15, 2025, the Company successfully completed the merger with Logan Ridge Finance Corporation (“LRFC”) with and into the Company, a major milestone...

~ Surpasses $100 Million in Annual Revenue, First Time in the Company’s History ~ ~ MAUs of 52 Million in Q4, Representing 11% Quarterly Sequential Growth ~ ~ Recently Launched Rumble Shorts Tops 1 Million Daily Unique Video Views ~ ~ On Track to Complete Transformative Acquisition of AI Infrastructure Company, Northern Data, in the Second Quarter of 2026 ~ ~ Northern Data’s GPU Utilization is Expected to Approximate 85% by End of Q1 20261 ~ LONGBOAT KEY, Fla., March 05, 2026 (GLOBE NEWSWIRE) — Rumble Inc. (Nasdaq: RUM), the Freedom-First technology platform, today announced financial results for the fiscal quarter and full year ended December 31, 2025. Q4 2025 Key Highlights and Key ItemsRevenue for the fourth quarter was $27.1 million, a sequential increase of 9% from $24.8 million in the third quarter of 2025. Average global...

TORONTO, March 05, 2026 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, today reported financial results for the fourth quarter and full year ended December 31, 2025. Unless specified otherwise, all amounts in this press release are expressed in U.S. dollars and are presented in accordance with U.S. generally accepted accounting principles (U.S. GAAP).   Business HighlightsQ4-2025 revenue grew 43% year-over-year and 13% sequentially quarter-over-quarter to a record $6.0 million.Profound’s TULSA-PRO® qualified sales pipeline also continues to grow, and currently stands at 110 new systems being classified within one of the “Verify, Negotiate and Contracting” stages. The...

BBOT debuted as a publicly traded oncology company developing a differentiated portfolio of three clinical-stage small molecule inhibitors targeting the RAS pathway. Announced encouraging preliminary safety and efficacy data across all three programs: BBO-8520’s differentiated efficacy and safety profile as monotherapy and at active doses in combination with pembrolizumab with a potentially differentiated liver toxicity profile, BBO-11818 producing the first publicly disclosed partial response in PDAC as a panKRAS inhibitor, and BBO-10203 showing no hyperglycemia without HbA1c restriction — establishing the clinical foundation for differentiated combination strategies, including BBOT’s internal KRAS plus PI3Kα breaker program. Clinical readouts expected in the second half of 2026 across all three programs, positioning BBOT for a...